[1]
G. Izquierdo, “Use of nirsevimab in extremely preterm infants: position of the Neonatal Infections Committee of the Chilean Society of Infectious Diseases”, Rev. Chilena. Infectol., vol. 43, no. 4, Jun. 2026.